Literature DB >> 2532366

Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans.

D L Vesely1, P Norsk, C J Winters, D M Rico, A L Sallman, M Epstein.   

Abstract

The role of peptides from the N terminus and C terminus of the 126 amino acid atrial natriuretic factor (ANF) prohormone in modulating renal sodium and water handling has not been defined. Since water immersion to the neck (NI) provides an acute central volume expansion identical to that produced by 2 liters of saline but without plasma compositional change, immersion to the neck was used to assess the N-terminal and C-terminal portions of the ANF prohormone response to acute central blood volume expansion in seven seated sodium-replete normal subjects. Both the C terminus, which contains amino acids 99-126 and is identical to ANF, and the whole N terminus (i.e., amino acids 1-98) increased promptly with NI and peaked after 1 hr of immersion. A Mr 3900 peptide from the midportion of the N terminus consistent with amino acids 31-67 (i.e., pro-ANF-31-67) also increased with NI and followed a pattern of increasing circulating concentration nearly identical to that of the whole N terminus of the prohormone, except that its maximal concentration was at the second hour of the 3 hr of NI. With cessation of immersion, ANF decreased to preimmersion levels within 1 hr whereas the N terminus and pro-ANF-31-67, although their circulating concentrations were decreasing, were still significantly elevated at 1 hr. These findings suggest that the increase in plasma ANF, the N terminus of the ANF prohormone, and pro-ANF-31-67 from the midportion of the N terminus, with natriuretic properties similar to ANF, contribute to the natriuretic response to NI, implying a physiologic role for these atrial peptides in modulating volume homeostasis in humans.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532366     DOI: 10.3181/00379727-192-42990

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  7 in total

1.  Four cardiac hormones increase circulating concentrations of luteinizing hormone and testosterone.

Authors:  David L Vesely; Gloria I San Miguel; Imran Hassan; William R Gower; Douglas D Schocken
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.633

2.  Peptides from the N-terminus of the atrial natriuretic factor prohormone enhance guanylate cyclase activity and increase cyclic GMP levels in a wide variety of tissues.

Authors:  D L Vesely
Journal:  Mol Cell Biochem       Date:  1992-01-15       Impact factor: 3.396

3.  Atrial natriuretic hormone prohormone gene expression in cardiac and extra-cardiac tissues of diabetic Goto-Kakizaki rats.

Authors:  William R Gower; Gloria I San Miguel; Gay M Carter; Imran Hassan; Robert V Farese; David L Vesely
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

4.  Atrial natriuretic peptide(31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2.

Authors:  M E Gunning; H R Brady; G Otuechere; B M Brenner; M L Zeidel
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 5.  Urodilatin: a better natriuretic peptide?

Authors:  David L Vesely
Journal:  Curr Heart Fail Rep       Date:  2007-09

Review 6.  Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases.

Authors:  Gustavo Jose Justo da Silva; Raffaele Altara; George W Booz; Alessandro Cataliotti
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

7.  Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours.

Authors:  Ehrentraud J Eichelbaum; Brian A Vesely; Abdel A Alli; Ying Sun; William R Gower; David L Vesely
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.